DrugRepV_1619 | Warfarin | Blood and Blood Forming Organs | Coagulation disorders | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | Approved | 24991006 |
DrugRepV_1620 | Palmitoylethanolamide | Antiviral | Respiratory viral infection | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | Experimental | 24991006 |
DrugRepV_1621 | Naltrexone | Nervous System | Alcohol dependence | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | Approved, Investigational, Vet approved | 24991006 |
DrugRepV_1622 | Minocycline | Antiinfectives For Systemic Use | Rocky Mountain spotted fever | Typhus fever and the typhus group | Q fever | Rickettsial pox | tick fevers caused by Rickettsiae | Upper respiratory tract infections caused by Streptococcus pneumoniae | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | Approved, Investigational | 24991006 |
DrugRepV_1623 | Lavendustin A | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |
DrugRepV_1624 | Imidapril | Cardiovascular agents | Autosomal dominant polycystic kidney disease (ADPKD) | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | Investigational | 24991006 |
DrugRepV_1625 | Glyburide | Alimentary Tract and Metabolism | Type 2 Diabetes Mellitus | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | Approved | 24991006 |
DrugRepV_1626 | Etalocib | Anticancer | Cancer | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | Investigational | 24991006 |
DrugRepV_1627 | Dobutamine | Cardiovascular agents | Myocardial infarction | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | Approved | 24991006 |
DrugRepV_1628 | D-serine | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | Approved | 24991006 |
DrugRepV_1629 | Carteolol | Cardiovascular agents | Anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | Approved | 24991006 |
DrugRepV_1630 | Candesartan cilexetil | Cardiovascular agents | Hypertension | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | Approved | 24991006 |
DrugRepV_1631 | Eptifibatide | Blood and Blood Forming Organs | Myocardial infarction | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | Approved | 24991006 |
DrugRepV_1632 | 2,2-Dipyridyl Disulfide | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | Experimental | 24991006 |
DrugRepV_1633 | Etalocib | Anticancer | Cancer | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | Investigational | 24991006 |
DrugRepV_1634 | Veratridine | Plant extract | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |
DrugRepV_1635 | Pobilukast | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |
DrugRepV_1636 | PD-180970 | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |
DrugRepV_1637 | Methylanthraniloyl guanosine triphosphate | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |
DrugRepV_1638 | Mastoparan | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |
DrugRepV_1639 | Hexadimethrine Bromide | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |
DrugRepV_1640 | Dideooxyforskolin | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |
DrugRepV_1641 | Compound 48/80 | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |
DrugRepV_1642 | 3-(N-methylanthraniloyl)-2-deoxy-ATP | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |
DrugRepV_1643 | 3-Aminotriazole | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |
DrugRepV_1644 | 2/3-O-N-methyanthraniloyl-ITP-gamma-S | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |
DrugRepV_1645 | 2/3-O-N-methyanthraniloyl-GTP-gamma-S | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |
DrugRepV_1646 | 2-(or3)-O-(N-methylanthranioyl)ATP | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |
DrugRepV_1647 | 2-Aminopurine | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |
DrugRepV_1648 | 1-cyclopropyl-3 | NA | NA | Influenza virus | A/Anhui/01/2013 | | Transcriptomic response-DEG | Decrease | NA | 24991006 |